DRAP1 Antikörper (AA 1-29)
Kurzübersicht für DRAP1 Antikörper (AA 1-29) (ABIN1808237)
Target
Alle DRAP1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 1-29
-
Spezifität
- This DRAP1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 1-29 amino acids from the N-terminal region of human DRAP1.
-
Aufreinigung
- Protein A purified
-
-
-
-
Applikationshinweise
- Approved: WB (1:1000)
-
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- PBS, 0.09 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.
-
Haltbarkeit
- 6 months
-
-
- DRAP1 (DR1-Associated Protein 1 (Negative Cofactor 2 Alpha) (DRAP1))
-
Andere Bezeichnung
- DRAP1
-
Hintergrund
-
Name/Gene ID: DRAP1
Synonyms: DRAP1, Nc2 alpha subunit, NC2-alpha, Negative cofactor 2 alpha, Dr1-associated corepressor, Dr1-associated protein 1, Negative co-factor 2-alpha -
Gen-ID
- 10589
-
UniProt
- Q14919
Target
-